4//SEC Filing
WADE JEFFREY L 4
Accession 0001127602-23-007917
CIK 0001062822other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 4:48 PM ET
Size
15.5 KB
Accession
0001127602-23-007917
Insider Transaction Report
Form 4
WADE JEFFREY L
EVP, Gen. Counsel
Transactions
- Exercise/Conversion
Common Stock
2023-02-28+11,176→ 235,323 total - Exercise/Conversion
Common Stock
2023-02-28+30,467→ 224,147 total - Exercise/Conversion
Restricted Stock Units
2023-02-28−37,273→ 74,547 total→ Common Stock (37,273 underlying) - Exercise/Conversion
Common Stock
2023-02-28+37,273→ 272,596 total - Exercise/Conversion
Restricted Stock Units
2023-02-28−30,467→ 0 total→ Common Stock (30,467 underlying) - Tax Payment
Common Stock
2023-02-28$2.17/sh−30,255$65,653→ 242,341 total - Exercise/Conversion
Restricted Stock Units
2023-02-28−11,176→ 11,177 total→ Common Stock (11,176 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
Documents
Issuer
LEXICON PHARMACEUTICALS, INC.
CIK 0001062822
Entity typeother
Related Parties
1- filerCIK 0001225767
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 4:48 PM ET
- Size
- 15.5 KB